远程医疗公司Hims & Hers Health Inc.(HIMS)今日盘前大涨9.78%,引发市场热议。这一强劲涨势主要受到公司前三季度财报数据优于预期的推动。
最新财报显示,Hims & Hers前三季度净利润达1亿美元,较去年同期亏损2,479.1万美元实现扭亏为盈。公司营收同比劲增58.9%至9.954亿美元,主要得益于其在线销售渠道的处方药和非处方产品销售表现突出。值得一提的是,Hims & Hers高达80.7%的毛利率为其获取更多利润奠定了坚实基础。
出色的业绩不难看出,Hims & Hers在远程医疗行业中占据了一席之地。公司不断致力于为患者提供更便捷的诊疗渠道,其服务和产品获得了用户的广泛好评。强劲的财务表现和增长潜力增强了投资者对该公司未来的信心,从而在盘前交易中积极买入该股。分析师普遍看好并给予"买入"评级,认为Hims & Hers股价仍有进一步上涨空间。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.